1315 Capital related stories
All articles and analysis
PE eyes customer loyalty in skincare brands: 8 dealsAdvent International, Bridgepoint, HealthEdge and MPK Equity are among several PE dealmakers eyeing investments in skincare brands.
1315 Capital acquires Argonaut's life sciences and diagnostics unitThe divested unit, now operating independently as Aluris Sciences, provides contract manufacturing for life sciences, diagnostics and combination drug product customers from formulation through commercial production.
Pharma packaging and storage services attract PE: Five deals1315 Capital, Aurora Capital and Platinum Equity are among the PE firms investing in the pharma packaging and storage services sector.
1315 Capital acquires pharma storage services provider SciSafeThe seller was BioLife Solutions.
1315 collects $500m across two fundsFund III beat its $350 million target while EGB exceeded its $150 million target.
Here are the 9 VCs in MassPRIM's diverse-manager portfolioOf the $424m MassPRIM committed to diverse managers last year, $158m went to four managers of venture capital and/or growth funds.
MassPRIM dedicated over $400m to diverse-owned PE managers in 2022Many LPs are focusing on re-ups with existing relationships due to the current economic landscape. LPs with dedicated programs may serve as a valuable lifeline for emerging and diverse-owned managers.
Emerging firm 1315 Capital scores pledge from LA City for its third fundLA City’s commitment is an example of a public pension system finding opportunities with newer funds and emerging managers despite the general preference of public system LPs to stick with established managers.
Onkos Surgical reels in $15m Series COnkos Surgical, a provider of solutions for musculoskeletal oncology and complex orthopaedic procedures, has raised $15 million in Series C funding.
